Analysts expect that ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) will post $94.83 million in sales for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for ACADIA Pharmaceuticals’ earnings. The lowest sales estimate is $87.40 million and the highest is $106.20 million. ACADIA Pharmaceuticals reported sales of $62.96 million during the same quarter […]
